.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Endoplasmic reticulum (ER) stress significantly drives the progression of liver cancer and shapes a hostile tumor microenvironment. Researchers recently investigated how PERK inhibition in HCC can mitigate these effects using the selective inhibitor AMG-PERK. They found that blocking the PERK signaling pathway reduces tumor burden and slows cell proliferation. Moreover, this intervention effectively shuts down the communication between tumor cells and the surrounding stroma. Therefore, targeting this pathway provides a dual benefit by attacking both malignant hepatocytes and their supportive environment.
The study reveals that ER stress enhances tumor-stromal crosstalk through the secretion of glycoprotein GP73. Specifically, GP73 activates hepatic stellate cells via GRP78-dependent signaling pathways. This activation promotes fibrosis and inflammation, which further fuel cancer growth. However, pharmacological PERK inhibition in HCC or the use of GRP78-targeting antibodies successfully blocks this fibrogenic response. Consequently, the researchers observed a marked reduction in inflammatory signaling and stromal activation within the tumor microenvironment.
Furthermore, transcriptomic profiling showed that PERK signaling drives several oncogenic programs, including MYC signaling and epithelial-to-mesenchymal transition. In contrast, inhibiting PERK reversed these aggressive features in both in vivo models and patient-derived organoids. Notably, single-cell RNA sequencing confirmed that PERK and GP73 are upregulated in malignant cells. Thus, these findings establish PERK as a critical driver of malignancy and a promising therapeutic target for early-stage hepatocarcinogenesis.
PERK inhibition reduces the activation of hepatic stellate cells and decreases fibrosis. By blocking the secretion of GP73, it disrupts the communication between tumor cells and the surrounding stroma, thereby limiting the pro-tumorigenic environment.
GP73 is a glycoprotein secreted by stressed hepatocytes that binds to GRP78 on hepatic stellate cells. This interaction triggers stellate cell activation, leading to increased fibrosis and inflammation that support tumor progression.
Yes, research indicates that PERK inhibition is particularly effective during early carcinogenesis. It restrains tumor development, impairs cell viability, and affects oncogenic programs like MYC signaling before the disease reaches advanced stages.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Khaled J et al. Inhibition of PERK signaling suppresses tumor progression and blocks GP73-GRP78-dependent stromal activation in hepatocellular carcinoma. Neoplasia. 2026 Jun 16. doi: undefined. PMID: 42302326.
Bobrovnikova-Marjon E et al. PERK promotes cancer cell proliferation and tumor growth by limiting oxidative DNA damage. Cancer Res. 2010;70(11):4323-4333.
Atkins C et al. Characterization of a novel PERK kinase inhibitor with antitumor and antiangiogenic activity. Cancer Res. 2013;73(6):1993-2002.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A groundbreaking study demonstrates that selective inhibition of the ER-stress sensor PERK suppresses hepatocellular carcinoma (HCC) progression. By blocking the GP73-GRP78 signaling pathway, this therapy reduces tumor burden and halts the activation of pro-tumorigenic hepatic stellate cells.
4 months ago
Depemokimab offers twice-yearly dosing for severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps, significantly cutting exacerbations and hospital admissions.
3 days back
A novel copper metal-organic framework hydrogel remodels the uterine microenvironment to stimulate robust endometrial regeneration, reduce intrauterine fibrosis, and restore reproductive fertility, offering a groundbreaking strategy for managing refractory endometrial damage and Asherman syndrome.
4 days back
New research reveals that non-ablative radiotherapy suppresses ventricular tachycardia by increasing conduction velocity via NaV1.5 upregulation and action potential prolongation. However, sustained sodium current elevation and depressed calcium handling highlight the need for careful clinical translation.
6 days back
A single-cell transcriptomic atlas reveals how peripheral nerve injuries cause dorsal root ganglion remodeling. By evaluating proximal nerve crush and resection, researchers identify distinct glial and immune programs that resolve neuropathic pain and promote regeneration.
4 days back
A breakthrough study demonstrates that fullerol-primed extracellular vesicles generated in a 3D SECCS bioreactor attenuate ferroptosis and restore myogenic regeneration in diabetes via the FOXO3 pathway, offering a cell-free therapeutic strategy for diabetic musculoskeletal degeneration.
4 days back
